| Pharmaceutical active ingredients: |
| Alendronic Acid (Alendronate Sodium) |
| Available forms, composition and doses of Fosalen: |
| N / A |
| Fosalen medical category: |
| Human:Agents affecting bone metabolismBone resorption inhibitorsMiscellaneous therapeutic agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| M05BA04 - Alendronic Acid |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Genepharma Group |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Findeclin | Alendronic Acid (Alendronate Sodium) | Finadiet |
| Fixopan | Alendronic Acid (Alendronate Sodium) | Novapharma, Venezuela |
| Forosa | Alendronic Acid (Alendronate Sodium) | Lek; Sandoz |
| Fosalan | Alendronic Acid (Alendronate Sodium) | Merck |
| Fosalan Once-Weekly | Alendronic Acid (Alendronate Sodium) | Merck |
| Fosamax Einmal Wochentlich | Alendronic Acid (Alendronate Sodium) | Merck |
| Fosamax Once Weekly | Alendronic Acid (Alendronate Sodium) | Merck |
| Fosval | Alendronic Acid (Alendronate Sodium) | Saval Laboratorios |
| Genalen | Alendronic Acid (Alendronate Sodium) | Gentili Istituto |
| Genalmen | Alendronic Acid (Alendronate Sodium) | Leti Laboratorios |